The association between systemic inflammation markers and the prevalence of hypertension

[1] Lawes CM(2008)International Society of H: Global burden of blood-pressure-related disease, 2001 Lancet 371 1513-1518

[2] Vander Hoorn S(2019)European and US guidelines for arterial hypertension: similarities and differences Eur J Intern Med 63 3-8

[3] Rodgers A(2020)The global epidemiology of hypertension Nat Rev Nephrol 16 223-237

[4] Angeli F(2021)Hypertension: do inflammation and immunity hold the key to solving this epidemic? Circ Res 128 908-933

[5] Reboldi G(2021)Pathophysiology of hypertension: the mosaic theory and beyond Circ Res 128 847-863

[6] Trapasso M(2022)Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study Postgrad Med 134 297-302

[7] Gentile G(2022)Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis Front Cardiovasc Med 9 106-1496

[8] Pinzagli MG(2022)Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke Eur J Med Res 27 10760296221146183-195

[9] Aita A(2022)The prognostic value of hematologic inflammatory markers in patients with acute coronary syndrome undergoing percutaneous coronary intervention Clin Appl Thromb Hemost 28 1481-1019

[10] Verdecchia P(2022)Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis Immunotherapy 14 188-267

[1] Lawes CM(2008)International Society of H: Global burden of blood-pressure-related disease, 2001 Lancet 371 1513-1518

[2] Vander Hoorn S(2019)European and US guidelines for arterial hypertension: similarities and differences Eur J Intern Med 63 3-8

[3] Rodgers A(2020)The global epidemiology of hypertension Nat Rev Nephrol 16 223-237

[4] Angeli F(2021)Hypertension: do inflammation and immunity hold the key to solving this epidemic? Circ Res 128 908-933

[5] Reboldi G(2021)Pathophysiology of hypertension: the mosaic theory and beyond Circ Res 128 847-863

[6] Trapasso M(2022)Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study Postgrad Med 134 297-302

[7] Gentile G(2022)Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis Front Cardiovasc Med 9 106-1496

[8] Pinzagli MG(2022)Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke Eur J Med Res 27 10760296221146183-195

[9] Aita A(2022)The prognostic value of hematologic inflammatory markers in patients with acute coronary syndrome undergoing percutaneous coronary intervention Clin Appl Thromb Hemost 28 1481-1019

[10] Verdecchia P(2022)Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis Immunotherapy 14 188-267